000 | 01829 a2200541 4500 | ||
---|---|---|---|
005 | 20250515224743.0 | ||
264 | 0 | _c20101104 | |
008 | 201011s 0 0 eng d | ||
022 | _a1432-0428 | ||
024 | 7 |
_a10.1007/s00125-010-1795-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFriedrichsen, M | |
245 | 0 | 0 |
_aDifferential aetiology and impact of phosphoinositide 3-kinase (PI3K) and Akt signalling in skeletal muscle on in vivo insulin action. _h[electronic resource] |
260 |
_bDiabetologia _cSep 2010 |
||
300 |
_a1998-2007 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Twin Study | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aBirth Weight _xphysiology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aGlucose Clamp Technique |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInsulin |
650 | 0 | 4 |
_aInsulin Receptor Substrate Proteins _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
650 | 0 | 4 |
_aObesity _xphysiopathology |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 |
_aReceptor, Insulin _xmetabolism |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aPoulsen, P | |
700 | 1 | _aRichter, E A | |
700 | 1 | _aHansen, B F | |
700 | 1 | _aBirk, J B | |
700 | 1 | _aRibel-Madsen, R | |
700 | 1 | _aStender-Petersen, K | |
700 | 1 | _aNilsson, E | |
700 | 1 | _aBeck-Nielsen, H | |
700 | 1 | _aVaag, A | |
700 | 1 | _aWojtaszewski, J F P | |
773 | 0 |
_tDiabetologia _gvol. 53 _gno. 9 _gp. 1998-2007 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-010-1795-8 _zAvailable from publisher's website |
999 |
_c19864170 _d19864170 |